AngioDynamics (ANGO) Reports In-Line Q2 EPS, Miss on Revenues; Lowers FY18 Revenue Guidance Below Consensus
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.27 -0.65%
Revenue Growth %: +6.3%
Financial Fact:
Income tax provision: 1.6M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +6.3%
Financial Fact:
Income tax provision: 1.6M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $86.7 million versus the consensus estimate of $88.42 million.
GUIDANCE:
AngioDynamics sees FY2018 EPS of $0.64-$0.68, versus the consensus of $0.66. AngioDynamics sees FY2018 revenue of $345-350 million, versus the consensus of $353.33 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Investing.com’s stocks of the week
- Redburn upgrades Southwest, stays bullish on Delta and United
Create E-mail Alert Related Categories
Corporate News, Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
